ENTA vs PH · rev $65.3M vs P/E 28, rev $19.85B
Enanta Pharmaceuticals Inc (ENTA) versus Parker-Hannifin Corporation (PH) — a side-by-side from cached financials, not a winner call.
Enanta Pharmaceuticals Inc (ENTA) is a biotechnology company listed on US.
Parker-Hannifin Corporation (PH) is a specialty industrial machinery company listed on US.
Latest reported ENTA revenue for 2025-09-30 was $65.3M. Net income was -$81.9M. Revenue was down 3.4% from 2024-09-30 to 2025-09-30. ENTA currently screens at market cap $328.0M.
Latest reported PH revenue for 2025-06-30 was $19.85B. Net income was $3.53B. PH currently screens at market cap $91.89B and trailing P/E 27.7.
ENTA currently screens at market cap $328.0M. PH currently screens at market cap $91.89B and trailing P/E 27.7.
Not investment advice. Open the ENTA and PH stock pages for the full models.
Not investment advice.